UTI: 200 mg qd x 7 days.
Skin and soft tissue infections: 200 mg q12h x 7 days.
Uncomplicated pyelonephritis: 400 mg q12h x 14 days
Pharyngitis/tonsillitis: 200 mg q12h x 10 days
Sinusitis/Upper/lower respiratory tract infection: 400 mg q12h.
[CRCL >50 ml/min]: Administer usual dose.
[10-49]: Administer 50% of usual dose at usual interval or usual dose
given half as often.
[<10 ]: Administer usual dose every 3-5 days.
Dose as for CrCl<10, on dialysis days give dose after dialysis
National Institutes of Health, U.S. National Library of Medicine,
DailyMed Database. Provides access to the latest drug monographs submitted to the
Food and Drug Administration (FDA). Please review the latest applicable package insert for
additional information and possible updates. A local search
option of this data can be found here.
The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical
judgment. Neither GlobalRPh Inc. nor any other party involved in the
preparation of this program shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material.PLEASE READ THE DISCLAIMER
BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU
AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. Read